Clinical trials
Terminated Lymphoma trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| ADC Therapeutics S.A. | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Hutchmed | 2 |
| Biomea Fusion Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Centro Nazionale Sangue | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| IGM Biosciences, Inc. | 1 |
| Kiadis Pharma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 24 |
| Lymphoma, Non-Hodgkin | 10 |
| Leukemia | 5 |
| Lymphoma, Large B-Cell, Diffuse | 5 |
| Neoplasms | 5 |
| Recurrence | 5 |
| Lymphatic Diseases | 4 |
| Lymphoproliferative Disorders | 4 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.